Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian markets open weak
Tue, 27 Oct 09:30 am

The major Asian stock markets have opened the day on a disappointing note. Stock markets in China, Indonesia and Hong Kong are trading down by 1.9%, 1.4% and 0.9% respectively. Major stock indices in Europe ended their previous session in red. However, stock market in US ended their previous session on a flattish note. The rupee is trading at 64.97 per US dollar.

Indian stock markets have too opened the day on a negative note. BSE-Sensex is trading lower by 91 points (down 0.3%) and NSE-Nifty is trading lower by 27 points (down 0.3%). S&P BSE Midcap and S&P BSE Smallcap are trading marginally lower by 0.06% and 0.2% respectively. Major sectoral indices have opened the day in red with stocks from banking and pharmaceutical sector witnessing maximum selling pressures.

HDFC reported its results for the quarter ended September 2015. The total income of the company reported a growth of 12.1% to Rs 74.80 bn on a YoY basis.

The loan book for the quarter grew by 18% on a YoY basis. The growth in the loan book was driven by the low margin retail loan book. However, bank's asset quality remained stable with the gross bad loan ratio at around 0.7%. The company's Net Interest Income (NII) grew by 17.9% to Rs 25.49 bn on a YoY basis. The NII stood at 3.95% during the quarter. The net profits of the company grew by 18.2% to Rs 16.04 bn.

As reported in financial daily, Nestle India has commenced the production of 'Maggi'. The move comes, after the brand cleared the safety tests.

Reportedly, the production has commenced in company's plant at Karnataka, Punjab and Goa. However, samples manufactured at these plants will be first sent to testing to the three accredited laboratories as directed by the Bombay High Court. The product will be available to the customers only after the samples are cleared by these laboratories.

Further, according to company's managing director the company hopes to bring the product back to the shop shelves by the year-end.

In one of our edition of the 5 Minute Wrap up, we had discussed about this controversy, as the stock of Nestle had tanked post this ban. And here is what we had written, - "Even if product quality suffers in the interim but is associated with a strong brand, the good image in mind of individuals remains intact. In the end, it all boils down to investing in wide moat companies. "Bigger the brand, wider the moat". Read this interesting piece, where we have discussed in detail on this.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian markets open weak". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.